Log In
Print this Print this

CRLX101 (formerly IT-101)

  Manage Alerts
Collapse Summary General Information
Company Arrowhead Pharmaceuticals Inc.
DescriptionNanoparticle-drug conjugate with a camptothecin payload that inhibits topoisomerase I (TOP1) and hypoxia-inducible factor 1 alpha (HIF1A; HIF1-alpha)
Molecular Target Topoisomerase I (TOP1) ; Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today